A novel approach to reducing postoperative intraperitoneal adhesions through the inhibition of insulinlike growth factor I activity

Archives of Surgery

Volumn 136, Issue 3, 2001, Pages 311-317

  Gimbel, Michael L ^a,b   Chelius, Dirk ^a,c   Hunt, Thomas K ^a,d   Spencer, E Martin ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; GLUCOCORTICOID; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN C; THYROID HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HYPOPHYSECTOMY; LAPAROTOMY; NONHUMAN; ORGAN WEIGHT; PERITONEUM ADHESION; PHLEBOTOMY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RAT; UTERUS HORN; WEIGHT REDUCTION;

EID: 0035094087     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.136.3.311     Document Type: Article

References (9)

1. Hunt T, Gimbel M. Postoperative adhesive disease. Perspect Colon Rectal Surg. 1998;11:83-91.
2. Ray NF, Larsen JW Jr, Stillman RJ, Jacobs RJ. Economic impact of hospitalizations for lower abdominal adhesiolysis in the United States in 1988. Surg Gynecol Obstet. 1993;176:271-276.
3. Mueller RV, Hunt TK, Tokunaga A, Spencer EM. The effect of insulinlike growth factor I on wound healing variables and macrophages in rats. Arch Surg. 1994;129:262-265.
4. Suh DY, Hunt TK, Spencer EM. Insulin-like growth factor-1 reverses the impairment of wound healing induced by corticosteroids in rats. Endocrinology. 1992;131:2399-2403.
5. Sommer A, Maack G, Spratt S, et al. Molecular genetics and actions of recombinant insulin-like growth factor binding protein-3. In: Spencer EM, ed. Modern Concepts of Insulin-like Grovrth Factors: Proceedings of the Second International Symposium on Insulin-like Growth Factors/Somatomedins Held January 12-16, 1991, in San Francisco, California. New York, NY: Elsevier Science Publishing; 1991:715-728.
6. Reece EA, Wiznitzer A, Le E, et al. The relation between human fetal growth and fetal blood levels of insulin-like growth factors I and II, their binding proteins, and receptors. Obstet Gynecol. 1994;84:88-95.
7. Frauman AG, Tsuzaki S, Moses AC. The binding characteristics and biological effects in FRTL5 cells of placental protein-12, an insulin-like growth factor-binding protein purified from human amniotic fluid. Endocrinology. 1989;124:2289-2296.
8. Clemmons D, Camacho-Hubner C, Jones J, et al. Insulin-like growth factor binding proteins: mechanisms of action at the cellular level. In: Spencer EM, ed. Modem Concepts of Insulin-like Growth Factors: Proceedings of the Second International Symposium on Insulin-like Growth Factors/Somatomedins Held January 12-16, 1991 in San Francisco, California. New York, NY: Elsevier Science Publishing; 1991:475-484.
9. Ritvos O, Rutanen EM, Pekonen F, et al. Characterization of functional type I insulin-like growth factor receptors from human choriocarcinoma cells. Endocrinology. 1988;122:395-401.